FGF21 increases cholesterol efflux by upregulating ABCA1 through the ERK1/2-PPARγ-LXRα pathway in THP1 macrophage-derived foam cells

DNA and Cell Biology

Volumn 33, Issue 8, 2014, Pages 514-521

  Lin, Xiao Long ^a,b   He, Xing Lan ^a   Zeng, Jun Fa ^a   Zhang, Hai ^a   Zhao, Yue ^a   Tan, Jian Kai ^a   Wang, Zuo ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Pathology Department People's Hospital of Huizhou   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 CHLORO 5 NITROBENZANILIDE; ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CHOLESTEROL; FIBROBLAST GROWTH FACTOR 21; LIVER X RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME MECHANISM; FOAM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOLIPOPROTEIN A-I; ATP BINDING CASSETTE TRANSPORTER 1; CELL LINE; CHOLESTEROL ESTERS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTORS; FOAM CELLS; GENE EXPRESSION; HUMANS; MAP KINASE SIGNALING SYSTEM; ORPHAN NUCLEAR RECEPTORS; PPAR GAMMA; UP-REGULATION;

EID: 84905280933     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2290     Document Type: Article

References (33)

1. An, S.Y., Lee, M.S., Yi, S.A., et al. (2012). Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques. Diabetes Res Clin Pract 96, 196-203.
2. Badman, M.K., Koester, A., Flier, J.S., Kharitonenkov, A., and Maratos-Flier, E. (2009). Fibroblast growth factor 21- deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 150, 4931-4940.
3. Costet, P., Luo, Y., Wang, N., Tall, A.R. (2000). Steroldependent transactivation of the abc1 promoter by the liver x receptor/retinoid x receptor. J Biol Chem 275, 28240-28245.
4. Cuevas-Ramos, D., Aguilar-Salinas, C.A., and Gómez-Pérez, F.J. (2012). Metabolic actions of fibroblast growth factor. Curr Opin Pediatr 2124, 523-529.
5. Ding, X., Boney-Montoya, J., Owen, B.M., Bookout, A.L., Coate, K.C., Mangelsdorf, D.J., and Kliewer, S.A. (2012). Cell Metab 16, 387-393.
6. Fisher, F.M., Estall, J.L., Adams, A.C., et al. (2011). Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. Endocrinology 152, 2996-3004.
7. Goetz, R. (2013). Metabolism: adiponectin-a mediator of specific metabolic actions of FGF21. Nat Rev Endocrinol 9, 506-508.
8. Habegger, K.M., Stemmer, K., Cheng, C., et al. (2013). Fibroblast growth factor 21 mediates specific glucagon actions. Diabetes 62, 1453-1463.
9. Hu, Y.W., Wang, Q., Ma, X., et al. (2010). TGF-beta1 upregulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophagederived foam cells. J Atheroscler Thromb 17, 493-502.
10. Hughes, S.E. (1997). Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 45, 1005-1019.
11. Iglesias, P., Selgas, R., Romero, S., and Díez, J.J. (2012). Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. Eur J Endocrinol 167, 301-309.
12. Jung, U.J., Torrejon, C., Chang, C.L., et al. (2012). Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPARγ. Arterioscler Thromb Vasc Biol 32, 2929-2937.
13. Kaplan, J.M., Hake, P.W., Denenberg, A., Nowell, M., Piraino, G., et al. (2010). Phosphorylation of extracellular signalregulated kinase (ERK)-1/2 is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis. Mol Med 16, 491-497.
14. Kharitonenkov, A., Wroblewski, V.J., Koester, A., et al. (2007). The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148, 774-781.
15. Kosinski, J.R., Hubert, J., and Carrington, P.E. (2012). The glucagon receptor is involved in mediating the body weightlowering effects of oxyntomodulin. Obesity (Silver Spring) 20, 1566-1571.
16. Kosola, S., Lampela, H., Gylling, H., et al. (2012). Cholesterol metabolism altered and FGF21 levels high after pediatric liver transplantation despite normal serum lipids. Am J Transplant 12, 2815-2824.
17. Li, A.C., Binder, C.J., Gutierrez, A., et al. (2004). Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by pparalpha, beta/delta, and gamma. J Clin Invest 114, 1564-1576.
18. Li, G., Gu, H.M., Zhang, D.W., et al. (2013). ATP-binding cassette transporters and cholesterol translocation. IUBMB Life 65, 505-512.
19. Li, H., Zhang, J., and Jia, W. (2013). Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology. Front Med 7, 25-30.
20. Lin, Z., Wu, Z., Yin, X., et al. (2010). Serum levels of FGF-21 are increased in coronary heart disease patientsand are independently associated with adverse lipid profile. PLoS One 5, e15534.
21. Liu, H.F., Cui, K.F., Wang, J.P., et al. (2012). Significance of ABCA1 in human carotid atherosclerotic plaques. Exp Ther Med 4, 297-302.
22. Liu, X.Y., Lu, Q., Ouyang, X.P., et al. (2013). Apelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C α signaling in THP-1 macrophagederived foam cells. Atherosclerosis 226, 398-407.
23. Lü, Y., Liu, J.H., Zhang, L.K., et al. (2010). Fibroblast growth factor 21 as a possible endogenous factor inhibits apoptosis in cardiac endothelial cells. Chin Med J (Engl) 123, 3417-3421.
24. Mulay, V., Wood, P., Manetsch, M., et al. (2013). Inhibition of mitogen-activated protein kinase Erk1/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells. PLoS One 8, e62667.
25. Nakaya, K., Tohyama, J., and Naik, S.U. (2011). Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway. Arterioscler Thromb Vasc Biol 31, 1276-1282.
26. Ozasa, H., Ayaori, M., Iizuka, M., et al. (2011). Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies. Atherosclerosis 219, 141-150.
27. Ross, R. (1999). Atherosclerosis-an inflammatory disease. N Engl J Med 340, 115-126.
28. Smith, J.D., Le Goff, W., Settle, M., Brubaker, G., Waelde, C., Horwitz, A., and Oda, M.N. (2004). ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I. J Biol Chem 279, 9963-9969.
29. Tian, C., Ye, X., Zhang, R., et al. (2013). Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARγ-adiponectin pathway. PLoS One 8, e53796.
30. Voloshyna, I., Hai, O., Littlefield, M.J., Carsons, S., and Reiss, A.B. (2013). Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine. Eur J Pharmacol 698, 299-309.
31. Wagner, B.L., Valledor, A.F., Shao, G., et al. (2003). Promoter specificroles for liver x receptor/corepressor complexes in the regulationof abca1 and srebp1 gene expression. Mol Cell Biol 23, 5780-5789.
32. Woo, Y.C., Xu, A., Wang, Y., and Lam, K.S. (2013). Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. Clin Endocrinol (Oxf) 78, 489-496.
33. Yokoyama, S. (2006). ABCA1 and biogenesis of HDL. J Atheroscler Thromb 13, 1-15.